Is dobutamine stress echocardiography useful for noninvasive differentiation of ischemic from idiopathic dilated cardiomyopathy?

Angiology

Volumn 48, Issue 9, 1997, Pages 783-793

  Cohen, Ariel ^a   Chauvel, Christophe ^a   Benhalima, Bouziane ^a   Guyon, Philippe ^a   Desert, Isabelle ^a   Valty, Jean ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE WALL MOTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0030773404     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979704800905     Document Type: Article

References (32)

1. Berthe C, Piérard LA, Hiernaux M, et al: Predicting the extent and location of coronary artery disease in acute inferior myocardial infarction by echocardiography during dobutamine infusion. Am J Cardiol 58:1167-1172, 1986.
2. Sawada SG, Segar SS, Ryan T, et al: Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 83:1605-1614, 1991.
3. Bach DS, Armstrong WF: Dobutamine stress echocardiography. Am J Cardiol 69:90H-96H, 1992.
4. Medina R, Panidis IP, Morganroth J, et al: The value of echocardiographic regional wall motion abnormalities in detecting coronary artery disease in patients with or without a dilated left ventricle. Am Heart J 109:799-803, 1985.
5. Greenberg JM, Murphy JH, Okada RD, et al: Value and limitations of radionuclide angiography in determining the cause of reduced left ventricular ejection fraction: Comparison of idiopathic dilated cardiomyopathy and coronary artery disease. Am J Cardiol 55:541-544, 1985.
6. Diaz RA, Nihoyannopoulos P, Athanassopoulos G, et al: Usefulness of echocardiography to differentiate dilated cardiomyopathy from coronary-induced congestive heart failure. Am J Cardiol 68:1224-1227, 1991.
7. Sharp SM, Sawada SG, Segar DS, et al: Dobutamine stress echocardiography: Detection of coronary artery disease in patients with dilated cardiomyopathy. J Am Coll Cardiol 24:934-939, 1994.
8. Afridi I, Kleiman NS, Raizner AE, et al: Dobutamine echocardiography in myocardial hibernation: Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 91:663-670, 1995.
9. Schiller NB, Shah PM, Crawford M, et al for the American Society of Echocardiography Commitee on andards, subcommittee on quantitation of two-dimensional echocardiograms: J Am Soc Echocardiogr 2:358-367, 1989.
10. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307-310, 1986.
11. Tauberg SG, Orie JE, Bartlett BE, et al: Usefulness of Thallium-201 for distinction of ischemic from idiopathic dilated cardiomyopathy. Am J Cardiol 71:674-680, 1993.
12. Mody FV, Brunken RC, Stevenson LW, et al: Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography. J Am Coll Cardiol 17:373-383, 1991.
13. Glantz SA: Is it all in numbers? J Am Coll Cardiol 21:835-837, 1993.
14. Lewis SJ, Sawada SG, Khouri S, et al: High dose dobutamine echocardiography detects myocardial viability and ischemia in coronary cardiomyopathy (abstract). J Am Coll Cardiol 125A, 1995.
15. Sklenar J, Ismail S, Villanueva FS, et al: Dobutamine echocardiography for determining the extent of myocardial salvage after reperfusion: An experimental evaluation. Circulation 90:1502-1512, 1994.
16. Mohaved A, Reeves WC, Rose GC, et al: Dobutamine and improvement of regional and global left ventricular function in coronary artery disease. Am J Cardiol 66:375-377, 1990.
17. Bendersky R, Chatterjee K, Parmley WW, et al: Dobutamine in chronic ischemic heart failure: Alterations in LV function and coronary hemodynamics. Am J Cardiol 48:554-558, 1981.
18. Pozen RG, DiBianco R, Katz RJ, et al: Myocardial metabolic and hemodynamic effects of dobutamine in heart failure complicating coronary artery disease. Circulation 63:1279-1285, 1981.
19. . Mertes H, Sawada SG, Ryan T, et al: Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography: Experience in 1118 patients. Circulation 88:15-19, 1993.
20. Poldermans D, Fioretti PM, Boersma E, et al: Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease. Am J Cardiol 73:456-459, 1994.
21. Picano E, Mathias W, Pingitore A, et al on behalf of the Echo Dobutamine International Cooperative Study Group: Safety and tolerability of dobutamine-atropine stress echocardiography: A prospective multicentric study. Lancet 344:1190-1192, 1994.
22. Cohen A, Chauvel C, Benhalima B, et al: Complication of dobutamine stress echocardiography (letter). Lancet 345:201-202, 1995.
23. La Canna G, Alfieri O, Giubbini R, et al: Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 23:617-626, 1994.
24. Cigarroa CG, DeFilippi CR, Brickner E, et al: Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 88:430-436, 1993.
25. Arnese M, Cornel JH, Salustri A, et al: Prediction of improvement of regional left ventricular function after surgical revascularization: A comparison of low-dose dobutamine echocardiography with 201Th single-photon emission computed tomography. Circulation 91:2748-2752, 1995.
26. . Charney R, Schwinger ME, Chun J, et al: Dobutamine echocardiography and resting-redistribution thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization. Am Heart J 128:864-869, 1994.
27. Mertes H, Segar D, Johnson M, et al: Assessment of hibernating myocardium by dobutamine stimulation in a canine model. J Am Coll Cardiol 26:1348-1355, 1995.
28. Perrone-Filardi P, Pace L, Prastaro M, et al: Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 91:2556-2565, 1995.
29. DeFilippi CR, Willet DL, Irani WN, et al: Comparison of myocardial contrast echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease. Circulation 92:2863-2868, 1995.
30. Baer FM, Voth E, Schneider CA, et al: Comparison of low dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with (18 F) fluorodeoxyglucose in patients with chronic coronary artery disease, a functional and morphological approach to the detection of residual myocardial viability. Circulation 91:1006-1015, 1995.
31. Castini D, Gentile F, Ornaghi M, et al: Dobutamine echocardiography: Usefulness of digital image processing. Eur Heart J 16:1420-1424, 1995.
32. Parodi O, DeMaria R, Oltrona L, et al: Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation. Circulation 88:509-522, 1993.